Details, Fiction and Deoxynivalenol
Pharmacological inhibition from the ataxia telangiectasia and Rad3-associated protein serine/threonine kinase (ATR; often known as FRAP-associated protein (FRP1)) has emerged like a promising system for cancer therapy that exploits synthetic lethal interactions with proteins involved in DNA damage repair, overcomes resistance to other therapies and